Overview
Recursion OS is a drug discovery and development platform that leverages massive biological and chemical datasets and advanced AI models to accelerate the identification of novel therapeutic targets and design optimized molecules. The platform utilizes an automated wet lab with robotics and computer vision to generate millions of cell experiments weekly, capturing high-dimensional phenomic, transcriptomic, proteomic, and ADME data. This data fuels intelligent machine learning models, enabling rapid target identification and molecule design. Recursion OS aims to reduce the high failure rate of traditional drug discovery by providing novel insights and precision design, leading to potential first-in-class and best-in-class treatments for conditions with high unmet need, including aggressive cancers and rare diseases. It significantly improves speed, efficiency, and reduces costs from hit identification to IND-enabling studies compared to traditional pharmaceutical company averages.